AlloMend
-
Biologics
AlloSource Launches AlloMend Duo Acellular Dermal Matrix, A Natural Solution For Non-Directional Implantation In Soft Tissue Reconstruction
CENTENNIAL, Colo., May 25, 2023 /PRNewswire/ — AlloSource®, one of the largest nonprofit allograft providers in the U.S. creating innovative cellular and…
Read More » -
Biologics
AlloSource Launches Allomend Extra-large Acellular Dermal Matrix
New dermal graft has the largest footprint within the AlloMend product line to support demanding soft tissue applications in plastic…
Read More » -
Biologics
AlloSource Launches AlloMend Ultra-Thick Acellular Dermal Matrix
New allograft is the thickest in the AlloMend product line to support demanding soft tissue applications CENTENNIAL, Colo., Aug. 11, 2021 /PRNewswire/…
Read More »